EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 236 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2019. The put-call ratio across all filers is 4.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,458,000 | -2.4% | 59,866 | +3.3% | 0.09% | +7.0% |
| Q4 2021 | $2,518,000 | +26.9% | 57,929 | +46.2% | 0.09% | +26.5% |
| Q3 2021 | $1,984,000 | -21.5% | 39,633 | -1.2% | 0.07% | -16.0% |
| Q2 2021 | $2,527,000 | -14.4% | 40,118 | +26.3% | 0.08% | -21.4% |
| Q1 2021 | $2,952,000 | +45.6% | 31,775 | +40.5% | 0.10% | +30.4% |
| Q4 2020 | $2,027,000 | +7.2% | 22,618 | +23.7% | 0.08% | -8.1% |
| Q3 2020 | $1,890,000 | -21.6% | 18,287 | -40.0% | 0.09% | -22.5% |
| Q2 2020 | $2,412,000 | +27.8% | 30,495 | -6.6% | 0.11% | +16.8% |
| Q1 2020 | $1,888,000 | -16.1% | 32,633 | -21.8% | 0.10% | +31.9% |
| Q4 2019 | $2,251,000 | -1.8% | 41,724 | -4.8% | 0.07% | -2.7% |
| Q3 2019 | $2,292,000 | -8.9% | 43,847 | -15.8% | 0.07% | +13.8% |
| Q2 2019 | $2,515,000 | – | 52,068 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |